An integrated microfluidic and fluorescence platform for probing in vivo neuropharmacology

Sean C Piantadosi,Min-Kyu Lee,Mingzheng Wu,Huong Huynh,Raudel Avila,Carina Pizzano,Catalina A Zamorano,Yixin Wu,Rachael Xavier,Maria Stanslaski,Jiheon Kang,Sarah Thai,Youngdo Kim,Jinglan Zhang,Yonggang Huang,Yevgenia Kozorovitskiy,Cameron Good,Anthony Banks,John A Rogers,Michael R Bruchas

DOI: https://doi.org/10.1101/2024.05.14.594203

2024-05-14

Abstract:Neurotechnologies and genetic tools for dissecting neural circuit functions have advanced rapidly over the past decade, although the development of complementary pharmacological methodologies has comparatively lagged. Understanding the precise pharmacological mechanisms of neuroactive compounds is critical for advancing basic neurobiology and neuropharmacology, as well as for developing more effective treatments for neurological and neuropsychiatric disorders. However, integrating modern tools for assessing neural activity in large-scale neural networks with spatially localized drug delivery remains a major challenge. Here, we present a dual microfluidic-photometry platform that enables simultaneous intracranial drug delivery with neural dynamics monitoring in the rodent brain. The integrated platform combines a wireless, battery-free, miniaturized fluidic microsystem with optical probes, allowing for spatially and temporally specific drug delivery while recording activity-dependent fluorescence using genetically encoded calcium indicators (GECIs), neurotransmitter sensors GRAB and GRAB , and neuropeptide sensors. We demonstrate the performance this platform for investigating neuropharmacological mechanisms in vivo and characterize its efficacy in probing precise mechanistic actions of neuroactive compounds across several rapidly evolving neuroscience domains.

Neuroscience

What problem does this paper attempt to address?

The main issue this paper attempts to address is the understanding of precise drug mechanisms in neuropharmacology and their application in neurobiology and the treatment of neuropsychiatric disorders. Specifically, the paper introduces a platform that combines microfluidics and fluorescence technology, aimed at enabling neuropharmacological research under in vivo conditions. This platform integrates a wireless, battery-free, and miniaturized fluidic system with optical probes, allowing for spatially and temporally specific drug delivery within the mouse brain while simultaneously recording neural dynamics. This method overcomes the problems of large equipment size, severe brain tissue damage, and restricted animal movement range associated with traditional methods, enabling researchers to better understand the mechanisms of action of neuroactive compounds, particularly at different neural pathways and receptor levels. Additionally, the platform can be used for various experimental protocols, including optogenetics, pharmacology, and photopharmacology research.